Drug Repurposing: a Shortcut to New Biological Entities

35Citations
Citations of this article
68Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Drug repurposing has proved to be an efficient alternative to drug discovery owing to the facts that it is economical and risk factors being much lower or even negligible as the drug has already been approved for having safe use in humans. The contrast of drug discovery from drug repurposing, its advantages and the challenges faced during the process are the important factors to be considered in drug repurposing. The approaches in drug discovery include three methods namely computational, biological and mixed. Moreover, the recent advancement in application of drugs for COVID-19 proved drug repurposing is a vital strategy in medical science for the upcoming years.

Cite

CITATION STYLE

APA

Rao, N., Poojari, T., Poojary, C., Sande, R., & Sawant, S. (2022). Drug Repurposing: a Shortcut to New Biological Entities. Pharmaceutical Chemistry Journal, 56(9), 1203–1214. https://doi.org/10.1007/s11094-022-02778-w

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free